Back to Search
Start Over
High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial
- Source :
- Journal of Contemporary Brachytherapy
- Publication Year :
- 2014
- Publisher :
- Termedia Publishing House, 2014.
-
Abstract
- Purpose: To compare the outcome of our facility with another about the shortened schedule (60 Gy in 10 fractions to 54 Gy in 9 fractions) of high-dose-rate interstitial brachytherapy (HDR ISBT) for mobile tongue cancer. Material and methods: Eighteen patients were treated with HDR ISBT as a monotherapy in dose reduction schedule with some unique technique to determine the border of tumor accuracy (lugol’s staining and metal marker), and to minimize adverse effect (lead-lined silicon block) at our facility. Results: The 2-year local and regional control rates and cause-specific survival rate were 82%, 80%, and 83% and moderate to severe late complications occurred in five patients (28%), which were almost the same treatment results achieved by another facility. Conclusions: We recommend 54 Gy in 9 fractions over 7 days as a feasible treatment to reduce patient discomfort in mobile tongue cancer patients. J Contemp Brachytherapy 2014; 6, 1: 10–14 DOI: 10.5114/jcb.2014.40726
- Subjects :
- medicine.medical_specialty
Original Paper
business.industry
medicine.medical_treatment
Interstitial brachytherapy
Brachytherapy
tongue cancer
Cancer
medicine.disease
High-Dose Rate Brachytherapy
Surgery
Oncology
dose reduction
high-dose-rate brachytherapy
medicine
Radiology, Nuclear Medicine and imaging
Dose reduction
Adverse effect
business
Nuclear medicine
Survival rate
Mobile tongue
Subjects
Details
- Language :
- English
- ISSN :
- 20812841 and 1689832X
- Volume :
- 6
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Journal of Contemporary Brachytherapy
- Accession number :
- edsair.doi.dedup.....76f80e88d5d334348d49167417b90874